RecallDepth
Class II Completed

Oxybutynin Chloride Extended-Release Tablet USP, 10 mg, 100 count bottles Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-256-01.

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
October 19, 2023
Posted
November 15, 2023
Recall Number
D-0097-2024
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Pennington, NJ, United States

Reason for Recall

Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

Distribution

Nationwide.

Lot / Code Info

M213318, exp. date 11/2024; M213314, exp. date 11/2024; M213315, exp. date 11/2024; M214436, exp. date 11/2024; M214437, exp. date 11/2024; M214438, exp. date 11/2024; M300653, exp. date 12/2024; M300654, exp. date 12/2024

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls